Showing posts with label Alzheimer's disease. Show all posts
Showing posts with label Alzheimer's disease. Show all posts

Friday, October 23, 2009

Retinal changes may be associated with Alzheimer's

Neuroscientists at the University of California-Irvine have discovered that the retinas of laboratory mice, whose genes have been altered so they develop Alzheimer's disease, experience changes similar to those in the brains of humans who have the disease.
Alzheimer's, affects over 5 million people in the U.S. and is the leading cause of elderly dementia. Brain imaging techniques are useful, but retinal imaging could be less invasive, less expensive and easier to perform.
For a study appearing in the November issue of The American Journal of Pathology, UCI neuroscientist Zhiqun Tan and colleagues analyzed the retinas of Alzheimer's mice that had been treated with immunotherapy.
Specifically, in both the retinas and brains, there is an accumulation of amyloid plaque lesions, a hallmark of the disease in brain imaging tests. Researchers said that the findings will be crucial to developing retinal imaging technology that could help diagnose and treat people with Alzheimer's Disease.

Tuesday, October 13, 2009

visuospatial skills decline three years before Alzheimer's

HealthDay reported that, according to a study published in the Oct. issue of the Archives of Neurology, the ability to perceive relationships between objects (visuospatial skills) may decline years before a person is diagnosed with Alzheimer's disease. In a study population of 444 people, researchers from the University of Kansas used data from "cognitive assessments" to chart declines in various areas before participants were diagnosed with dementia. They found an inflection point (sudden change to a steeper slope of decline) in visuospatial abilities three years before clinical diagnosis of dementia. After that, "declines in overall cognition occurred the next year, while inflection points for verbal and working memory weren't seen until one year before diagnosis."

The UK's Telegraph quotes the authors as saying that "research into early detection of cognitive disorders using only episodic memory tasks, such as word lists or paragraph recall, may not be sensitive to either all of the earliest manifestations of disease or the most rapidly changing domain.
Reblog this post [with Zemanta]

Monday, August 10, 2009

Alzheimer's Patients have difficulty perceiving certain kinds of visual contrast

Memory loss in Alzheimer's disease conceals dramatic changes to vision which may make people seem less mentally competent than they actually are.

Researchers are now testing whether they could improve the lives of people with Alzheimer's by helping them see better, using low-tech interventions such as colored dinner plates, oversize change purses, and special bingo cards. The scientists believe that small changes, such as making sure patients can see a light switch or the edge of a stair, could have important consequences for their independence and quality of life.

Researchers from Dr Alice Cronin-Golomb's lab at Boston University have discovered that Alzheimer's patients have difficulty picking up on certain kinds of visual contrast. Unfortunately, the vision loss does not show up on a typical eye exam. So the problem may be blamed on memory, when it really is eyesight. A new rule of thumb may be that if you want a person with Alzheimer's to be able to see something, use bold contrasting colors.

One of the BU group’s collaborators, Grover C. Gilmore, dean of the Mandel School of Applied Social Sciences at Case Western Reserve University, has found that healthy adults were able to identify letters faster than Alzheimer’s patients. Normally, such a delay might be chalked up to memory problems. But when he increased the visual contrast, he found that the difference between the two groups disappeared.


Reblog this post [with Zemanta]

Thursday, July 16, 2009

A new paradigm for understanding glaucoma has emerged

Glaucoma isn't simply an eye disease, experts now say, but rather a degenerative nerve disorder, not unlike Alzheimer's or Parkinson's disease.

While researchers still recognize high pressure within the eye as a leading risk factor for glaucoma, it is becoming clear that the condition begins with injury to the optic nerve as it exits the back of the eye. The damage then spreads, moving from one nerve cell to adjoining nerve cells.

Neeru Gupta, MD, PhD, of the University of Toronto, explained, In glaucoma, we've shown that when your retinal ganglion cells are sick, the long axons that project from the eye into the brain are also affected, resulting in changes that we can detect in the vision center of the brain. This phenomenon, called transynaptic damage, occurs in Alzheimer's and Parkinson's disease, as well.

Reblog this post [with Zemanta]

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review